EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Renin Inhibition and eNOS Upregulation as Novel Mechanisms of Antihypertensive Food Peptides

Tolulope Joshua Ashaolu iD

Cell Biochemistry and Function · 2026

DOI: 10.1002/cbf.70163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, 2026. Verfasst von Tolulope Joshua Ashaolu. Beteiligte Einrichtung: Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam. Hauptthemen laut MEDLINE: Antihypertensive Agents, Nitric Oxide Synthase Type III, Up-Regulation, Renin Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Food‐derived bioactive peptides are gaining significant attention as safer, natural alternatives to synthetic drugs for managing hypertension. While research has predominantly focused on angiotensin‐converting enzyme (ACE) inhibition, the frequent disconnect between in vitro potency and in vivo efficacy suggests the involvement of alternative molecular mechanisms. This review critically assesses recent literature regarding two pivotal non‐ACE inhibitory pathways: the inhibition of renin, the rate‐limiting enzyme of the renin‐angiotensin system (RAS), and the upregulation of endothelial nitric oxide synthase (eNOS). We examine insights from studies characterizing peptides acting through these pathways and discuss emerging mechanisms such as angiotensin II receptor blockade and the ACE2/Ang(1‐7)/MasR axis. Furthermore, we identify critical knowledge gaps arising from methodological inconsistencies in in vivo assays and the limited number of in vivo validation studies. The evidence suggests that antihypertensive food peptides function through multifaceted mechanisms, offering a holistic approach to blood pressure regulation. Future research must prioritize integrated approaches combining in silico , in vivo, and in vivo models to bridge existing translational gaps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsNitric Oxide Synthase Type IIIUp-RegulationRenin InhibitorsHypertensionPeptidesHumansBioactive Peptides, DietaryAnimalsRenin-Angiotensin SystemReninAngiotensin-Converting Enzyme Inhibitors

Stichwörter der Autor:innen

ACE‐inhibitionantihypertensive peptidesendothelial NO synthase (eNOS)renin inhibitionrenin‐angiotensin system (RAS)

Substanzen

Antihypertensive AgentsNitric Oxide Synthase Type IIIBioactive Peptides, DietaryRenin InhibitorsPeptidesReninAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam.
  • Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.

ORCID-Profile: Tolulope Joshua Ashaolu

Zitieren

APA

Ashaolu, T. J. (2026). Renin Inhibition and eNOS Upregulation as Novel Mechanisms of Antihypertensive Food Peptides. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70163

Vancouver

Ashaolu TJ. Renin Inhibition and eNOS Upregulation as Novel Mechanisms of Antihypertensive Food Peptides. Cell Biochemistry and Function. 2026. doi:10.1002/cbf.70163

BibTeX
@article{Ashaolu2026,
  author = {Ashaolu, Tolulope Joshua},
  title = {Renin Inhibition and eNOS Upregulation as Novel Mechanisms of Antihypertensive Food Peptides},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  doi = {10.1002/cbf.70163}
}
Kostenlos starten →